Atrium Health has agreed to end what the federal government claimed are anticompetitive steering restrictions in contracts between commercial health insurers and its providers in the Charlotte, North Carolina service area, the Department of Justice (DOJ) announced.
If the settlement is approved by a federal judge, it will end two years of civil antitrust litigation that challenged Atrium’s alleged use of steering restrictions that prevented health insurers from promoting cost-effective healthcare services to consumers, the DOJ stated.
“Competition encourages healthcare providers to reduce costs, lower prices, and increase quality,” said Makan Delrahim, Assistant US Attorney General for the Antitrust Division. “Atrium’s steering restrictions interfered with the competitive process, resulting in fewer choices and higher costs for consumers.”
Featured News
Turkey Ends Meta Investigation Over Threads and Instagram
Dec 8, 2024 by
CPI
Supreme Court to Hear CCI Petition on Amazon, Flipkart Antitrust Cases
Dec 8, 2024 by
CPI
Senators Urge Antitrust Probe Into FanDuel and DraftKings
Dec 8, 2024 by
CPI
Novo Holdings Secures EU Approval for $16.5 Billion Catalent Acquisition
Dec 8, 2024 by
CPI
US Appeals Court Upholds TikTok Divestment Law, Paving Way for Potential Ban
Dec 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead